In comparison to controls the OR of EBV+ cHL was 2.09 (95% CI = 0.95–4.57, p = 0.066) and the OR for EBV− cHL was 0.33 (CI 0.13–0.86, p = 0.023) for HLA-A*02:07. This evidence concerns the gene HLA-A and classic Hodgkin lymphoma.